TOKYO–(BUSINESS WIRE)–FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing, completed the acquisition of Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Terms of the deal were not disclosed.
Located in Warminster, Pennsylvania, Shenandoah Biotechnology manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade� line of cytokines and growth factors that are manufactured according to cGMP guidelines in the Companys new state-of-the-art, ISO 9001:2015 certified facility.
Shenandoah Biotechnologys portfolio of recombinant proteins complements FUJIFILM Irvine Scientific, Inc.s advanced cell culture solutions and expertise in bioprocessing, which will provide customers with a single point of access for their life science research, discovery, and cell and gene therapy needs.
Contacts
Lily Jeffery
Zyme Communications
Phone: +44 (0)7891 477 378
Email: lily.jeffery@zymecommunications.com
WASHINGTON, D.C., UNITED STATES - Media OutReach Newswire - 29 April 2024 - #NTT DATA,…
DUBLIN--(BUSINESS WIRE)--The "Global Cordless Power Tools Market - Outlook & Forecast 2023-2028" report has been…
COLUMBUS, Ohio, April 29, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core…
DUBLIN--(BUSINESS WIRE)--The "Carotenoid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031…
Barbeques Galore digitally transforms its outdated, monolithic B2B system into an intuitive, scalable B2B storefront…
CHICAGO & BENGALURU, India--(BUSINESS WIRE)--#AI--MathCo, a global leader in Enterprise AI and analytics, today announced…
